Ok
I agree that the RC220 new formulation will be far more convenient, practical etc and likely have the same benefits as RC110 but I assume that bringing it to market will need the company to start over in the pathway to market to satisfy regulators etc ?
( Happy to be wrong with this and look forward to educated comments as I admit I’m not all over the process and it just my thoughts)
I thought these current trial results to be good and hopefully for holders the market reflects that . There is still a road ahead though
RAC Price at posting:
91.5¢ Sentiment: None Disclosure: Not Held
